1. Myopia Control Effect of Repeated Low-Level Red-Light Therapy Combined with Orthokeratology: A Multicenter Randomized Controlled Trial.
- Author
-
Xiong, Ruilin, Wang, Wei, Tang, Xianghua, He, Meinan, Hu, Yin, Zhang, Jian, Du, Bei, Jiang, Yu, Zhu, Zhuoting, Chen, Yanping, Zhang, Shiran, Kong, Xiangbin, Wei, Ruihua, Yang, Xiao, and He, Mingguang
- Subjects
- *
VISUAL acuity , *ORTHOKERATOLOGY , *CONFIDENCE intervals , *MYOPIA , *CLINICAL trials - Abstract
To investigate the efficacy and safety of repeated low-level red-light (RLRL) therapy combined with orthokeratology among children who, despite undergoing orthokeratology, exhibited an axial elongation of at least 0.50 mm over 1 year. Multicenter, randomized, parallel-group, single-blind clinical trial (ClinicaTrials.gov identifier, NCT04722874). Eligible children were 8–13 years of age with a cycloplegic spherical equivalent refraction of –1.00 to –5.00 diopters at the initial orthokeratology fitting examination and had annual axial length (AL) elongation of ≥0.50 mm despite undergoing orthokeratology. Forty-eight children were enrolled from March 2021 through January 2022, and the final follow-up was completed in March 2023. Children were assigned randomly to the RLRL therapy combined with orthokeratology (RCO) group or to the orthokeratology group in a 2:1 ratio. The orthokeratology group wore orthokeratology lenses for at least 8 hours per night, whereas the RCO group received daily RLRL therapy twice daily for 3 minutes in addition to orthokeratology. The primary outcome was AL change measured at 12 months relative to baseline. The primary analysis was conducted in children who received the assigned intervention and completed at least 1 follow-up after randomization using the modified intention-to-treat principle. Forty-seven children (97.9%) were included in the analysis (30 in the RCO group and 17 in the orthokeratology group). The mean axial elongation rate before the trial was 0.60 mm/year and 0.61 mm/year in the RCO and orthokeratology groups, respectively. After 12 months, the adjusted mean AL changes were –0.02 mm (95% confidence interval [CI], –0.08 to +0.03 mm) in the RCO group and 0.27 mm (95% CI, 0.19–0.34 mm) in the orthokeratology group. The adjusted mean difference in AL change was –0.29 mm (95% CI, –0.44 to –0.14 mm) between the groups. The percentage of children achieving an uncorrected visual acuity of more than 20/25 was similar in the RCO (64.3%) and orthokeratology (65.5%) groups (P = 0.937). Combining RLRL therapy with orthokeratology may offer a promising approach to optimize axial elongation control among children with myopia. This approach also potentially allows children to achieve satisfactory visual acuity, reducing daytime dependence on corrective eyewear. Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF